Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3218397
Max Phase: Preclinical
Molecular Formula: C45H72N16O16
Molecular Weight: 1093.17
Molecule Type: Small molecule
Associated Items:
ID: ALA3218397
Max Phase: Preclinical
Molecular Formula: C45H72N16O16
Molecular Weight: 1093.17
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)N[C@H]1[C@H]([C@H](OC(=O)NCCCCCn2cc(CCCCCc3cn(CCCCCNC(=O)O[C@@H]([C@@H]4OC(C(=O)O)=C[C@H](NC(=N)N)[C@H]4NC(C)=O)[C@H](O)CO)nn3)nn2)[C@H](O)CO)OC(C(=O)O)=C[C@@H]1NC(=N)N
Standard InChI: InChI=1S/C45H72N16O16/c1-24(64)52-34-28(54-42(46)47)18-32(40(68)69)74-38(34)36(30(66)22-62)76-44(72)50-14-8-4-10-16-60-20-26(56-58-60)12-6-3-7-13-27-21-61(59-57-27)17-11-5-9-15-51-45(73)77-37(31(67)23-63)39-35(53-25(2)65)29(55-43(48)49)19-33(75-39)41(70)71/h18-21,28-31,34-39,62-63,66-67H,3-17,22-23H2,1-2H3,(H,50,72)(H,51,73)(H,52,64)(H,53,65)(H,68,69)(H,70,71)(H4,46,47,54)(H4,48,49,55)/t28-,29-,30+,31+,34+,35+,36+,37+,38+,39+/m0/s1
Standard InChI Key: FIEOAMJWPOPHIM-JOXSXFRGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1093.17 | Molecular Weight (Monoisotopic): 1092.5312 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Fraser BH, Hamilton S, Krause-Heuer AM, Wright PJ, Greguric I, Tucker SP, Draffan AG, Fokin VV, Sharpless KB. (2013) Synthesis of 1,4-triazole linked zanamivir dimers as highly potent inhibitors of influenza A and B, 4 (2): [10.1039/C2MD20300F] |
Source(1):